Michael Shulman Email & Phone Number
Managing Director, Clinical Science and Development Strategy @ Pharma Capital Partners L.P.
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Michael Shulman Location
- San Francisco, CA, US
Michael Shulman Work
- Managing Director, Clinical Science and Development Strategy @ (January 2014 - Present)
- Owner @ Biomedical Resources for Global Drug Development (January 2004 - Present)
- Scientific Advisory Board Member and Consultant @ (January 2001 - Present)
- Central Reviewer, Sle @ (March 2012 - March 2016)
- Medical Monitor @ (March 2014 - October 2014)
- Feasibility Consultant @ (May 2012 - June 2012)
- Clinical Consultant, Drug Development and Clinical Trials @ Coyote Pharmaceuticals, Inc. (October 2011 - March 2012)
- Consulting Medical Monitor and Safety Officer @ Celtic Pharma (September 2006 - October 2007)
- Consultant Medical Monitor and Safety Officer @ Neurobiological Technologies, Inc. (July 2005 - September 2007)
- Medical Safety Consultant @ (January 2006 - January 2006)
- Drug Safety Consultant @ (May 2004 - June 2005)
- u.s. Clinical Consultant @ (June 2003 - November 2003)
- Nephrology Consultant @ (March 2002 - August 2002)
- Renal Consultant @ Biostratum (August 2000 - September 2001)
- Vice President, Clinical Development @ Anergen (January 1997 - March 1999)
- Consultant @ Sangstat Medical Corporation (January 1995 - January 1996)
- Associate Director, Medical Research, Mycophenolate Mofetil Transplant Program @ Syntex Development Research (February 1994 - December 1994)
- Associate Director, Immunohematology and Cardiovascular, Medical Affairs @ (June 1991 - February 1994)
Michael Shulman Education
- Columbia University College of Physicians and Surgeons
Doctor Of Medicine (Medicine)
1961-1965 - University of North Carolina at Chapel Hill
(Medicine)
1958-1961
Michael Shulman Skills
- Clinical Trial Design
- CAR-T
- Standard of Care
- Translational Medicine
- Regulatory Requirements
- Good Clinical Practice (GCP)
- Clinical Research Experience
- Pharmaceuticals
- Kidney Transplant
- Kidney
- End Stage Renal Disease
- Investments
- Mergers & Acquisitions (M&A)
- M&A Due Diligence
- Deal Sourcing
- Business Planning
- Regulatory Submissions
- Clinical Monitoring
- Writing
- Respiratory Disease
- Autoimmune Disease
- Biotechnology
- Central Nervous System
- Clinical Development
- Clinical Documentation
- Clinical Protocol Development
- Clinical Protocol Review
- Clinical Protocols
- Clinical Research
- Clinical Safety
- Clinical Study Design
- Clinical Trial Feasibility Assessment
- Clinical Trials
- Data Analysis
- Drug Development
- Drug Safety
- FDA
- Immunology
- Leadership
- Life Sciences
- Management
- Medical Monitoring
- Medical Research
- Medical Writing
- Medicine
- Multiple Sclerosis
- Nephrology
- Pharmaceutical Industry
- Presentations
- Private Equity
- Rheumatology
- Strategic Planning
- Study Reports
- Transplantation
- Cardiovascular Disease
- Endocrine Metabolic
- Endocrine Metabolic Disorders
- Protocol Development
- Consulting
- Hypertension
- Neurology
- Transplant
- Sle
- Dialysis
- Good Clinical Practice Gcp
- Medical Devices
- Support
- Translational Research
- Pharmacovigilance
- Bilag Grading
- Neuro Oncology
- Lifesciences
- Protocol
- CRO Management
- Oncology
- Clinical Trial
- Pharmaceutical Companies
- GCP
- Pharmaceutics
- Diabetes
- Clinical Protocol
- Due Diligence
- Technology Transfer
- Medical Affairs
- Biomarkers
- Protein Chemistry
- IND
- Biopharmaceuticals
- Good Clinical Practice
Michael Shulman Summary
- Michael Shulman, based in San Francisco, CA, US, is currently a Managing Director, Clinical Science and Development Strategy at Pharma Capital Partners. Michael Shulman brings experience from previous roles at Biomedical Resources for Global Drug Development, Mountain View Pharmaceuticals, Inc., American Board of Internal Medicine and Pra Health Sciences. Michael Shulman holds a 1961 - 1965 Doctor Of Medicine in Medicine @ Columbia University College of Physicians and Surgeons. With a robust skill set that includes Clinical Trial Design, CAR-T, Standard of Care, Translational Medicine, Regulatory Requirements and more. Michael Shulman has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Shulman?
Find contact details for 700 million professionals.
Others Named Michael Shulman
Michael Shulman
Managing Director, Clinical Science and Development Strategy
San Francisco, CA, US
Michael Shulman
Chief Executive Officer and Partner
Farmington, MI, US
Michael Shulman
Vice President, Asset Management
Dallas, TX, US
Michael Shulman
Director of Engineering
Boston, MA, US
Michael Shulman
Partner
Melbourne, VIC, AU
Michael Shulman
Founder, Publisher, Editor
Las Vegas, NV, US
Michael Shulman
Partner
Washington, DC, US
Top Pharma Capital Partners L.P. Employees
Michael Shulman
Managing Director, Clinical Science and Development Strategy
San Francisco, CA, US
Peter Rayson
General Partner
Solihull, GB
Brendan MacMillan
General Partner
San Francisco, CA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co